INFLIXIMAB ANTIBODY Test
Test Name: INFLIXIMAB ANTIBODY Test
Components: Infliximab antibodies
Price: AED 1410.0
Sample Condition: 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: 1 week
Method: EIA (Enzyme Immunoassay)
Test Type: Disorders of Gastroenterological Tract, Inflammation
Doctor: Gastroenterologist, Rheumatologist
Test Department: IMMUNOASSAY
Pre Test Information: No special preparation required
What is the INFLIXIMAB ANTIBODY Test?
The INFLIXIMAB ANTIBODY Test is a blood test that measures the level of antibodies against infliximab in the bloodstream. Infliximab is a medication used to treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis.
Why is the INFLIXIMAB ANTIBODY Test performed?
The test is typically performed to determine if a patient has developed antibodies against infliximab, which can reduce the effectiveness of the medication. If the test shows a high level of antibodies, it may indicate that the patient is not responding well to infliximab treatment and may require a change in medication or dosage.
The test is usually done before starting infliximab treatment to establish a baseline level of antibodies, and then periodically during treatment to monitor for the development of antibodies over time. It can help guide treatment decisions and ensure that patients are receiving the optimal dose of infliximab for their condition.
Conclusion
The INFLIXIMAB ANTIBODY Test is an important tool in managing patients receiving infliximab therapy. It helps optimize treatment outcomes by monitoring the level of antibodies against infliximab in the bloodstream and guiding treatment decisions accordingly.
| Test Name | INFLIXIMAB ANTIBODY Test |
|---|---|
| Components | |
| Price | 1410.0 AED |
| Sample Condition | 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Report Delivery | 1 week |
| Method | EIA |
| Test type | Disorders of Gastroenterological Tract, Inflammation |
| Doctor | Gastroenterologist, Rheumatologist |
| Test Department: | IMMUNOASSAY |
| Pre Test Information | No special preparation required |
| Test Details | The infliximab antibody test is a blood test that measures the level of antibodies against infliximab in the bloodstream. Infliximab is a medication used to treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. The test is typically performed to determine if a patient has developed antibodies against infliximab, which can reduce the effectiveness of the medication. If the test shows a high level of antibodies, it may indicate that the patient is not responding well to infliximab treatment and may require a change in medication or dosage. The test is usually done before starting infliximab treatment to establish a baseline level of antibodies, and then periodically during treatment to monitor for the development of antibodies over time. It can help guide treatment decisions and ensure that patients are receiving the optimal dose of infliximab for their condition. Overall, the infliximab antibody test is an important tool in managing patients receiving infliximab therapy and can help optimize treatment outcomes. |
